Clinical Validation of a Unani Pharmacopoeial formulation â?? Habb-e-Bawaseer Damiya in BawÄ?sÄ«r DÄ?miya (Bleeding Piles)

Central Council for Research in Unani Medicine0 sites300 target enrollmentStarted: TBDLast updated: November 24, 2021

Trial Snapshot

No summary available.

•1. Patients of any sex in the age group 19 to 65 years
•2. Patients with a diagnosis of First and Second Degree Hemorrhoids presenting with any of the following symptoms:
•3.Bleeding Per Rectum (JarayÄ?n al-Dam fiâ??l Maqâ??ad): bright-red, painless bleeding
•4. Mucoid Anal/ Perianal Discharge (SayalÄ?n al-Maqâ??ad MukhÄ?tÄ«): mucus discharge
•5. Pruritus Ani (Hikka al-Maqâ??ad)
•6. Mucosal Prolapse (KhurÅ«j al-MukhÄ?tÄ«yya) with Spontaneous Reduction
•7. Rectal/ Anal Pain (Wajaâ?? al-Maqâ??ad): on prolapse

•1.Third & Fourth Degree Haemorrhoids, anal fissure, anal fistula, IBD, Diabetes Mellitus
•2.Known cases of other clinically significant co-morbid conditions (severe hepatic, renal, cardiovascular disorders, etc.) that in the opinion of the investigator could affect the efficacy and safety outcome of the study
•3.Patients with laboratory values outside the normal limits or those with values considered abnormal in the opinion of the investigator
•4.Known hypersensitivity to study drug or any of its ingredients
•5.History of alcohol and drug abuse
•6.Pregnant and Lactating Women

Sponsor